A Different Approach to Dermatology Care
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses:
- How they're positioning the company to capitalize on the unmet needs in other specific therapeutic areas
- Strategies to ensure long-term success in these spaces
- Patient centric initiatives they've implemented to ensure the patient voice is integrated into drug development and commercialization processes
- Their approach to orphan drug development
- Challenges and opportunities adapting to the US market
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
